Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
155.01
Dollar change
-0.39
Percentage change
-0.25
%
IndexDJIA, S&P 500 P/E25.62 EPS (ttm)6.05 Insider Own0.12% Shs Outstand2.41B Perf Week-0.32%
Market Cap372.27B Forward P/E14.64 EPS next Y10.59 Insider Trans-0.20% Shs Float2.40B Perf Month-3.49%
Income14.68B PEG4.27 EPS next Q2.02 Inst Own72.74% Short Float0.73% Perf Quarter-6.54%
Sales87.69B P/S4.25 EPS this Y0.33% Inst Trans0.66% Short Ratio2.70 Perf Half Y5.69%
Book/sh29.14 P/B5.32 EPS next Y6.37% ROA8.58% Short Interest17.48M Perf Year1.91%
Cash/sh8.45 P/C18.34 EPS next 5Y6.00% ROE20.89% 52W Range143.13 - 168.85 Perf YTD-1.10%
Dividend Est.4.68 (3.02%) P/FCF17.94 EPS past 5Y-0.27% ROI14.47% 52W High-8.20% Beta0.50
Dividend TTM4.91 (3.17%) Quick Ratio0.79 Sales past 5Y1.31% Gross Margin68.67% 52W Low8.30% ATR (14)2.36
Dividend Ex-DateNov 26, 2024 Current Ratio1.03 EPS Y/Y TTM15.10% Oper. Margin24.60% RSI (14)44.08 Volatility1.36% 1.49%
Employees131900 Debt/Eq0.51 Sales Y/Y TTM-8.03% Profit Margin16.75% Recom2.12 Target Price176.95
Option/ShortYes / Yes LT Debt/Eq0.45 EPS Q/Q-43.91% Payout84.93% Rel Volume0.88 Prev Close155.40
Sales Surprise1.35% EPS Surprise9.68% Sales Q/Q5.27% EarningsOct 15 BMO Avg Volume6.48M Price155.01
SMA20-0.19% SMA50-2.70% SMA200-0.52% Trades Volume5,687,821 Change-0.25%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Today 05:52AM
04:55AM
Nov-28-24 07:45AM
Nov-26-24 12:00PM
06:18AM
06:00AM Loading…
06:00AM
04:03AM
03:17AM
Nov-23-24 10:16AM
10:16AM
07:20AM
05:36AM
04:02AM
Nov-22-24 05:20PM
02:28PM
12:25PM Loading…
12:25PM
12:05PM
11:08AM
08:00AM
08:00AM
Nov-21-24 04:00PM
Nov-19-24 09:02AM
09:00AM
06:24AM
05:22AM
Nov-18-24 04:30PM
01:27PM
11:20AM
05:28AM
12:43AM
09:02AM Loading…
Nov-15-24 09:02AM
07:23AM
06:51AM
Nov-14-24 11:30AM
10:00AM
Nov-13-24 12:00PM
11:58AM
03:33AM
03:28AM
02:00AM
Nov-12-24 03:04PM
06:40AM
06:00AM
Nov-11-24 04:05PM
03:00AM
Nov-08-24 10:38AM
09:35AM
07:00AM
05:27AM
04:15AM
Nov-07-24 02:46PM
08:00AM
06:35AM
Nov-05-24 09:00AM
Nov-04-24 06:35PM
03:11PM
Nov-01-24 08:35AM
07:47AM
Oct-31-24 04:00AM
Oct-29-24 09:19AM
09:19AM
08:00AM
06:32AM
Oct-28-24 12:33PM
12:09PM
11:32AM
07:30AM
Oct-27-24 12:16PM
Oct-26-24 07:30AM
Oct-25-24 01:19PM
08:05AM
05:37AM
Oct-24-24 01:28PM
10:26AM
08:00AM
08:00AM
05:21AM
04:00AM
01:02AM
Oct-23-24 05:03PM
09:00AM
04:30AM
Oct-22-24 01:13AM
Oct-21-24 05:03PM
03:33PM
11:26AM
10:47AM
09:57AM
05:30AM
Oct-20-24 11:00AM
Oct-19-24 05:40PM
09:57AM
Oct-18-24 03:25PM
02:34PM
08:27AM
05:10AM
Oct-17-24 08:18AM
04:14AM
Oct-16-24 04:04PM
02:31PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM